Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (231-240 of 357) with videos related to

Pageof 36
Sort By:
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
European Journal of Gastroenterology & Hepatology|September 24, 2025
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world studyChristopher Ma, Ulrike von Arm, Frank Zerbib, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or UstekinumabAnne Hu, Paulo Gustavo Kotze, Alice Burgevin, et al.
The American Journal of Gastroenterology|May 19, 2023
Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisBabu P Mohan, Noor Fatima, Shahab R Khan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative ColitisChristopher Ma, William J Sandborn, Geert R D'Haens, et al.
BMC Gastroenterology|September 5, 2012
Postoperative complications following colectomy for ulcerative colitis: a validation studyChristopher Ma, Marcelo Crespin, Marie-Claude Proulx, et al.
Bipolar Disorders|January 19, 2018
Prevalence of cognitive impairment in major depression and bipolar disorderKatie M Douglas, Peter Gallagher, Lucy J Robinson, et al.
Therapeutic Advances in Gastroenterology|October 8, 2025
Adalimumab around the world: comparative analysis of products characteristics and patient support systemsTsz Hong Yiu, Emilia Anderson, Wai Keung Leung, et al.
Therapeutic Advances in Gastroenterology|April 2, 2026
Increased failure of budesonide MMX for ulcerative colitis during the COVID-19 pandemic: a population-based studyStephanie Coward, Karen J B Martins, Scott Klarenbach, et al.
Pageof 36

Showing results (231-240 of 357) with videos related to

Sort By:
Pageof 36
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
Alimentary Pharmacology & Therapeutics|October 16, 2025
Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel DiseasesDhruv Ahuja, Soo-Kyung Park, Kuan-Hung Yeh, et al.
European Journal of Gastroenterology & Hepatology|September 24, 2025
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world studyChristopher Ma, Ulrike von Arm, Frank Zerbib, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or UstekinumabAnne Hu, Paulo Gustavo Kotze, Alice Burgevin, et al.
The American Journal of Gastroenterology|May 19, 2023
Early Remission With Induction Therapy Predicts Long-Term Remission in Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisBabu P Mohan, Noor Fatima, Shahab R Khan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative ColitisChristopher Ma, William J Sandborn, Geert R D'Haens, et al.
BMC Gastroenterology|September 5, 2012
Postoperative complications following colectomy for ulcerative colitis: a validation studyChristopher Ma, Marcelo Crespin, Marie-Claude Proulx, et al.
Bipolar Disorders|January 19, 2018
Prevalence of cognitive impairment in major depression and bipolar disorderKatie M Douglas, Peter Gallagher, Lucy J Robinson, et al.
Therapeutic Advances in Gastroenterology|October 8, 2025
Adalimumab around the world: comparative analysis of products characteristics and patient support systemsTsz Hong Yiu, Emilia Anderson, Wai Keung Leung, et al.
Therapeutic Advances in Gastroenterology|April 2, 2026
Increased failure of budesonide MMX for ulcerative colitis during the COVID-19 pandemic: a population-based studyStephanie Coward, Karen J B Martins, Scott Klarenbach, et al.
Pageof 36